NASDAQ:AMPH
Amphastar Pharmaceuticals Stock News
$43.48
+0.740 (+1.73%)
At Close: May 17, 2024
AMPH Stock Price Increased Over 5% Pre-Market: Why It Happened
08:27am, Monday, 29'th Mar 2021
The stock price of Amphastar Pharmaceuticals Inc (NASDAQ: AMPH) increased by over 5% pre-market. This is why it happened.
Amphastar Pharmaceuticals Receives FDA Approval for Dextrose Injection
06:00am, Monday, 29'th Mar 2021
RANCHO CUCAMONGA, Calif., March 29, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) approved the Company's Abbr
New Strong Sell Stocks for March 18th
08:43am, Thursday, 18'th Mar 2021
Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q4 2020 Results - Earnings Call Transcript
08:11pm, Monday, 15'th Mar 2021
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q4 2020 Results - Earnings Call Transcript
Amphastar Pharmaceuticals (AMPH) Surpasses Q4 Earnings and Revenue Estimates
06:31pm, Monday, 15'th Mar 2021
Amphastar (AMPH) delivered earnings and revenue surprises of 14.29% and 7.42%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Recap: Amphastar Pharmaceuticals Q4 Earnings
05:00pm, Monday, 15'th Mar 2021
Shares of Amphastar Pharmaceuticals (NASDAQ:AMPH) rose in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 128.57% year over year to $0.16, wh
Amphastar Pharmaceuticals Reports Financial Results for the Three Months and Full-Year Ended December 31, 2020
04:05pm, Monday, 15'th Mar 2021
Reports Net Revenues of $95.9 Million for the Three Months Ended December 31, 2020 Reports Net Revenues of $95.9 Million for the Three Months Ended December 31, 2020
Amphastar Pharmaceuticals to Release Fourth Quarter Earnings and Hold Conference Call on March 15th, 2021
05:39pm, Monday, 08'th Mar 2021
RANCHO CUCAMONGA, Calif., March 08, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced that the Company will release results for its fourth quarter of 2020 ended Decembe
Amphastar Pharmaceuticals to Present at the Raymond James 2021 Institutional Healthcare Conference
06:01am, Friday, 26'th Feb 2021
RANCHO CUCAMONGA, Calif., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) announced today that Bill Peters, CFO, Dan Dischner, V.P of Corporate Communications and HR,
Amphastar Announces Approval for Glucagon for Injection Kit, 1mg
06:00am, Tuesday, 29'th Dec 2020
RANCHO CUCAMONGA, Calif., Dec. 29, 2020 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc., (NASDAQ: AMPH) announced that the U.S. Food and Drug Administration (“FDA”) has approved its Abbrevia
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2020 Results - Earnings Call Transcript
10:49pm, Sunday, 08'th Nov 2020
Amphastar Pharmaceuticals, Inc. (AMPH) Management on Q3 2020 Results - Earnings Call Transcript
Amphastar Pharmaceuticals' (AMPH) Management on Q3 2020 Results - Quick Version Earnings Call Transcript
02:05pm, Friday, 06'th Nov 2020
Amphastar Pharmaceuticals' (AMPH) Management on Q3 2020 Results - Quick Version Earnings Call Transcript
Amphastar Pharmaceuticals Reports Financial Results for the Three Months Ended September 30, 2020
06:50am, Friday, 06'th Nov 2020
Reports Net Revenues of $83.4 Million for the Three Months Ended September 30, 2020 Reports Net Revenues of $83.4 Million for the Three Months Ended September 30, 2020
The Global Preclinical Respiration and Inhalation Lab Equipment Market will grow by $ 2.26 mn during 2020-2024
Amphastar Pharmaceuticals (AMPH) Presents at Wells Fargo Securities 2020 Virtual Healthcare Conference - Slideshow
05:42pm, Friday, 11'th Sep 2020
The following slide deck was published by Amphastar Pharmaceuticals, Inc. in conjunction with this event..
